Sponsor

Panntherapi

France 10 Rue Descartes, 30000 Nimes, France

About the sponsor

Panntherapi’s clinical research activity is centered on epilepsy, with interest in the treatment and management of seizure disorders and related neurological symptoms.

Seizure control
Antiepileptic therapy
Neurological disorder management

The sponsor’s research focus reflects a targeted commitment to central nervous system therapeutics within the field of neurology.

About Specializations

Panntherapi runs clinical trials in conditions such as Epilepsy, among others.

Epilepsy

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

2 clinical trials

Epilepsy

Not yet recruiting

InvestigationalNo placebo

Long‑Term Safety and Tolerability of Probenecid (PTI5803) as Adjunctive Therapy in Patients ≥14 Years with Drug‑Resistant Focal Epilepsy due to Focal Cortical Dysplasia

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years
Sponsor:Panntherapi

Contact Research Centre

Epilepsy

Not yet recruiting

InvestigationalNo placebo

Safety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years
Sponsor:Panntherapi

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →

About the sponsor

About Specializations

Ongoing trials

2 clinical trials

Epilepsy

Long‑Term Safety and Tolerability of Probenecid (PTI5803) as Adjunctive Therapy in Patients ≥14 Years with Drug‑Resistant Focal Epilepsy due to Focal Cortical Dysplasia

Epilepsy

Safety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia

Are you running a clinical trial?

Prefer not to search? Our Concierge searches the trials for you.